Regeneron's Inmazeb gained FDA approval Oct. 14, becoming the first Ebola treatment to receive approval by the agency.

Pfizer received FDA approval to test the COVID-19 vaccine it's developing with BioNTech in children as young as 12, one of the trial's lead researchers told CNN Oct. 13.

Walgreens Boots Alliance shared its financial results for the fiscal year and fourth quarter that ended Aug. 31, reporting earnings that were higher than its expectations and predicting single-digit profit growth in 2021.

Clinical trial experts say that pauses in AstraZeneca and Johnson & Johnson's COVID-19 vaccine trials are normal and to be expected, but a halt in Eli Lilly's trial for its antibody drug is more rare and concerning, The New York Times reported. 

The National Institutes of Health said Eli Lilly's trial of its COVID-19 antibody drug was halted due to the "clinical status" of multiple participants, according to a statement reviewed by The New York Times. 

The government's plan to send $200 drug savings cards to millions of Medicare beneficiaries won't be completed until after Election Day, a person familiar with the plan told The Wall Street Journal.  

Rite Aid said Oct. 13 it is starting a paid time off program for all of its workers on Election Day.

A Dutch payer has won a lawsuit accusing AstraZeneca of creating an unfair monopoly on an antipsychotic drug by using a patent that had been invalidated to block generic competition, STAT reported. 

The CDC's Oct. 16 deadline for states to submit their COVID-19 vaccine distribution plans is rapidly approaching, but states are still struggling to address the significant uncertainties and logistical challenges surrounding mass COVID-19 inoculation in the U.S., according to Bloomberg Law.

Seven health systems are uniting to form the Health System Owned Specialty Pharmacy Alliance, or HOSP, to advocate for health system-owned specialty pharmacies. 

Harrisonburg (Va.) Community Health Center has rebranded itself Healthy Community Health Centers and opened a pharmacy, a local ABC-TV affiliate, reported.

HHS Secretary Alex Azar said earlier this year that any potential COVID-19 vaccine injuries will be covered under a program called the Countermeasures Injury Compensation Program, which shields drugmakers from liability for any potential injuries that occur due to their vaccines, The Wall Street Journal reported. 

Eli Lilly's clinical trial of its experimental COVID-19 antibody drug has been paused due to a safety concern, according to an email obtained by Brief19, a COVID-19-related medical research news site created by three physicians.    

Pfizer's breast cancer drug Ibrance did not meet its goal of improving invasive disease-free survival in patients with early-stage breast cancer, the drugmaker announced Oct. 9.

Johnson & Johnson voluntarily paused the clinical trial for its COVID-19 vaccine candidate Oct. 12 after learning of a participant's unexplained illness, STAT reported.

Ten hospitals and health systems posted job listings seeking pharmacy leaders in the last week.

Several national pharmacy associations are celebrating Women Pharmacist Day Oct. 12, a day created by Suzanne Soliman, PharmD, to honor female trailblazers in the pharmacy profession. 

After the FDA said in May that it found unacceptable levels of a carcinogen in popular diabetes drug metformin, several drugmakers began recalling their metformin products. 

The National Institutes of Health has begun studying remdesivir in combination with a highly concentrated solution of COVID-19 antibodies to see if it can reduce the risk of patients developing more serious illness. 

HHS will pay pharma giant AstraZeneca $486 million to secure as many as 100,000 doses of its experimental COVID-19 antibody drug, as well as support clinical trials for the treatment.